Connect Biopharma Holdings (CNTB) Amortizatization of Intangibles (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted quarterly Amortizatization of Intangibles of $7000.0 for Q1 2026, down 97.19% year-on-year from $249000.0 in Q1 2025, and down 89.55% on a QoQ basis from $67000.0 in Q4 2025.
Connect Biopharma Holdings (CNTB) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings (CNTB) has reported Amortizatization of Intangibles for 3 consecutive years, with $7000.0 the latest figure, recorded in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 97.19% year-over-year to $7000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $531000.0 (up 87.63% YoY) and the FY2025 annual result came in at $773000.0, up 528.46% from the prior year.
- Amortizatization of Intangibles eased to $7000.0 in Q1 2026 per CNTB's latest filing, from $67000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for CNTB reached as high as $288000.0 in Q2 2025 and fell as low as $7000.0 in Q1 2026.
- A 3-year average of $112875.0 and a median of $78000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2025 — Amortizatization of Intangibles soared 2780.0% — and 2026, when it plunged 97.19%.
- Year by year, Amortizatization of Intangibles stood at $24000.0 in 2024, then jumped by 179.17% to $67000.0 in 2025, then slumped by 89.55% to $7000.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $7000.0, $67000.0, and $169000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Connect Biopharma Holdings | 120.44 Mn | 120.44 Mn | - | 7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | 67,000.00 |
| Dec 31, 2025 | 67,000.00 |
| Sep 30, 2025 | 169,000.00 |
| Sep 30, 2025 | 169,000.00 |
| Jun 30, 2025 | 288,000.00 |
| Jun 30, 2025 | 288,000.00 |
| Mar 31, 2025 | 249,000.00 |
| Mar 31, 2025 | 249,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | 89,000.00 |
| Mar 31, 2024 | 89,000.00 |